Scientific Advisory Board
Scientific Advisory Board
About our SAB Members
The Institute is supported by an international Scientific Advisory Board comprising eight world-leading scientists. We greatly value their insight and guidance on our current research as well as helping shape our overall research strategy.
- Professor Ron Hay – Chair
University of Dundee - Professor Jos Jonkers
Netherlands Cancer Institute - Professor Gillian Griffiths
Cambridge Institute for Medical Research - Professor Andreas Trumpp
German Cancer Research Centre
- Professor Doug Lauffenburger
Massachusetts Institute of Technology - Professor Maddy Parsons
King’s College London - Professor Nuria Lopez-Bigas
IRB Barcelona - Professor Kristian Helin
The Institute of Cancer Research
Professor Ronald Hay FRS FRSE FMedSci
Ron Hay is a Professor in the Division of Molecular Cell and Developmental Biology at the University of Dundee.
His laboratory is focused on establishing the role of ubiquitin and ubiquitin-like proteins in important biological processes. They have been working on a number of projects linking SUMO modification to ubiquitylation, in stress responses, DNA damage and arsenic therapy and in determining the mechanism of E3 ligase mediated conjugation.
Professor Jos Jonkers
Jos Jonkers is based in the Netherlands Cancer Institute (NKI) where he focuses on mouse models of breast cancer.
His group studies human breast cancer development and progression, as well as therapy response and resistance, in genetically engineered mouse models (GEMMs) and patient-derived tumour xenograft (PDX) models.
Professor Gillian Griffiths FMedSci, FRS
Gillian Griffiths is Professor of Cell Biology and Immunology at the University of Cambridge and is the Director of the Cambridge Institute for Medical Research. She is a cell biologist and immunologist and her research is focussed on control of secretion at the immunological synapse.
Her lab studies the mechanisms that control secretion within the immunological synapse using a range of functional, biochemical and imaging techniques.
Professor Andreas Trumpp
Prof. Dr. Andreas Trumpp is based at the German Cancer Research Centre where he is Head of the Division of Stem Cells and Cancer, as well as Managing Director of the Heidelberg Institute for Stem Cell Technology and Experimental Medicine.
His research goal is to explore stem cell biology with relation to cancer diseases and develop novel strategies for identification and targeting of cancer and metastasis stem cells.
Professor Doug Lauffenburger
Professor Lauffenburger is the Ford Professor of Engineering based at the Massachusetts Institute of Technology in Boston. He leads the research group ‘Translational systems biology’.
His lab work on the integration of experimental and mathematical/computational analysis toward development and validation of predictive models in terms of underlying molecular and cellular network properties.
Professor Maddy Parsons
Professor Maddy Parsons is a Professor of Cell Biology in the Randall Centre for Cell & Molecular Biophysics at King’s College London.
Her research interests are focussed in the biomedical and life sciences arena. Her lab study cell adhesion receptors and how different receptor families control cytoskeleton remodelling and cell migration.
Professor Nuria Lopez-Bigas
Professor Nuria Lopez-Bigas is based at the IRB Barcelona, where she leads the Biomedical Genomics research group focused on the study of cancer from a genomics perspective.
She is particularly interested in the identification of cancer driver mutations, genes and pathways across tumour types and in the study of their potential as therapeutic targets.
Professor Kristian Helin
Professor Kristian Helin is the Chief Executive and President of The Institute of Cancer Research, London.
His Epigenetics and Cancer Group studies the role of chromatin-associated proteins (epigenetics) in the regulation of transcription, cell fate decisions and in cancer.